154 related articles for article (PubMed ID: 22302350)
1. Somatic mutations in the Notch, NF-KB, PIK3CA, and Hedgehog pathways in human breast cancers.
Jiao X; Wood LD; Lindman M; Jones S; Buckhaults P; Polyak K; Sukumar S; Carter H; Kim D; Karchin R; Sjöblom T
Genes Chromosomes Cancer; 2012 May; 51(5):480-9. PubMed ID: 22302350
[TBL] [Abstract][Full Text] [Related]
2. Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer.
Board RE; Wardley AM; Dixon JM; Armstrong AC; Howell S; Renshaw L; Donald E; Greystoke A; Ranson M; Hughes A; Dive C
Breast Cancer Res Treat; 2010 Apr; 120(2):461-7. PubMed ID: 20107891
[TBL] [Abstract][Full Text] [Related]
3. PIK3CA mutation associates with improved outcome in breast cancer.
Kalinsky K; Jacks LM; Heguy A; Patil S; Drobnjak M; Bhanot UK; Hedvat CV; Traina TA; Solit D; Gerald W; Moynahan ME
Clin Cancer Res; 2009 Aug; 15(16):5049-59. PubMed ID: 19671852
[TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of PI3K/AKT signaling pathway in tamoxifen exemestane adjuvant multinational pathology study.
Sabine VS; Crozier C; Brookes CL; Drake C; Piper T; van de Velde CJ; Hasenburg A; Kieback DG; Markopoulos C; Dirix L; Seynaeve C; Rea DW; Bartlett JM
J Clin Oncol; 2014 Sep; 32(27):2951-8. PubMed ID: 25071141
[TBL] [Abstract][Full Text] [Related]
5. Integrative genomic analyses on GLI1: positive regulation of GLI1 by Hedgehog-GLI, TGFbeta-Smads, and RTK-PI3K-AKT signals, and negative regulation of GLI1 by Notch-CSL-HES/HEY, and GPCR-Gs-PKA signals.
Katoh Y; Katoh M
Int J Oncol; 2009 Jul; 35(1):187-92. PubMed ID: 19513567
[TBL] [Abstract][Full Text] [Related]
6. PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression.
Shah V; Nowinski S; Levi D; Shinomiya I; Kebaier Ep Chaabouni N; Gillett C; Grigoriadis A; Graham TA; Roylance R; Simpson MA; Pinder SE; Sawyer EJ
Breast Cancer Res; 2017 Jan; 19(1):7. PubMed ID: 28095868
[TBL] [Abstract][Full Text] [Related]
7. PIK3CA mutations rarely demonstrate genotypic intratumoral heterogeneity and are selected for in breast cancer progression.
Kalinsky K; Heguy A; Bhanot UK; Patil S; Moynahan ME
Breast Cancer Res Treat; 2011 Sep; 129(2):635-43. PubMed ID: 21617917
[TBL] [Abstract][Full Text] [Related]
8. Mutational analysis of NOTCH1, 2, 3 and 4 genes in common solid cancers and acute leukemias.
Lee SH; Jeong EG; Yoo NJ; Lee SH
APMIS; 2007 Dec; 115(12):1357-63. PubMed ID: 18184405
[TBL] [Abstract][Full Text] [Related]
9. Molecular Insights of Pathways Resulting from Two Common PIK3CA Mutations in Breast Cancer.
Bhat-Nakshatri P; Goswami CP; Badve S; Magnani L; Lupien M; Nakshatri H
Cancer Res; 2016 Jul; 76(13):3989-4001. PubMed ID: 27197157
[TBL] [Abstract][Full Text] [Related]
10. PIK3CA mutation impact on survival in breast cancer patients and in ERα, PR and ERBB2-based subgroups.
Cizkova M; Susini A; Vacher S; Cizeron-Clairac G; Andrieu C; Driouch K; Fourme E; Lidereau R; Bièche I
Breast Cancer Res; 2012 Feb; 14(1):R28. PubMed ID: 22330809
[TBL] [Abstract][Full Text] [Related]
11. The PIK3CA gene is mutated with high frequency in human breast cancers.
Bachman KE; Argani P; Samuels Y; Silliman N; Ptak J; Szabo S; Konishi H; Karakas B; Blair BG; Lin C; Peters BA; Velculescu VE; Park BH
Cancer Biol Ther; 2004 Aug; 3(8):772-5. PubMed ID: 15254419
[TBL] [Abstract][Full Text] [Related]
12. Detection of PIK3CA gene mutations with HRM analysis and association with IGFBP-5 expression levels in breast cancer.
Dirican E; Kaya Z; Gullu G; Peker I; Ozmen T; Gulluoglu BM; Kaya H; Ozer A; Akkiprik M
Asian Pac J Cancer Prev; 2014; 15(21):9327-33. PubMed ID: 25422220
[TBL] [Abstract][Full Text] [Related]
13. Breast Cancer Heterogeneity Examined by High-Sensitivity Quantification of PIK3CA, KRAS, HRAS, and BRAF Mutations in Normal Breast and Ductal Carcinomas.
Myers MB; Banda M; McKim KL; Wang Y; Powell MJ; Parsons BL
Neoplasia; 2016 Apr; 18(4):253-63. PubMed ID: 27108388
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling reveals new aspects of PIK3CA mutation in ERalpha-positive breast cancer: major implication of the Wnt signaling pathway.
Cizkova M; Cizeron-Clairac G; Vacher S; Susini A; Andrieu C; Lidereau R; Bièche I
PLoS One; 2010 Dec; 5(12):e15647. PubMed ID: 21209903
[TBL] [Abstract][Full Text] [Related]
15. Novel mutant-enriched sequencing identified high frequency of PIK3CA mutations in pharyngeal cancer.
Qiu W; Tong GX; Manolidis S; Close LG; Assaad AM; Su GH
Int J Cancer; 2008 Mar; 122(5):1189-94. PubMed ID: 17990317
[TBL] [Abstract][Full Text] [Related]
16. Identification of Variant-Specific Functions of PIK3CA by Rapid Phenotyping of Rare Mutations.
Dogruluk T; Tsang YH; Espitia M; Chen F; Chen T; Chong Z; Appadurai V; Dogruluk A; Eterovic AK; Bonnen PE; Creighton CJ; Chen K; Mills GB; Scott KL
Cancer Res; 2015 Dec; 75(24):5341-54. PubMed ID: 26627007
[TBL] [Abstract][Full Text] [Related]
17. PIK3CA-activating mutations and chemotherapy sensitivity in stage II-III breast cancer.
Liedtke C; Cardone L; Tordai A; Yan K; Gomez HL; Figureoa LJ; Hubbard RE; Valero V; Souchon EA; Symmans WF; Hortobagyi GN; Bardelli A; Pusztai L
Breast Cancer Res; 2008; 10(2):R27. PubMed ID: 18371219
[TBL] [Abstract][Full Text] [Related]
18. Somatic mutation and gain of copy number of PIK3CA in human breast cancer.
Wu G; Xing M; Mambo E; Huang X; Liu J; Guo Z; Chatterjee A; Goldenberg D; Gollin SM; Sukumar S; Trink B; Sidransky D
Breast Cancer Res; 2005; 7(5):R609-16. PubMed ID: 16168105
[TBL] [Abstract][Full Text] [Related]
19. Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients.
Chen L; Yang L; Yao L; Kuang XY; Zuo WJ; Li S; Qiao F; Liu YR; Cao ZG; Zhou SL; Zhou XY; Yang WT; Shi JX; Huang W; Hu X; Shao ZM
Nat Commun; 2018 Apr; 9(1):1357. PubMed ID: 29636477
[TBL] [Abstract][Full Text] [Related]
20. Mutational characterization of individual breast tumors: TP53 and PI3K pathway genes are frequently and distinctively mutated in different subtypes.
Boyault S; Drouet Y; Navarro C; Bachelot T; Lasset C; Treilleux I; Tabone E; Puisieux A; Wang Q
Breast Cancer Res Treat; 2012 Feb; 132(1):29-39. PubMed ID: 21512767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]